Clinical Trial Update: A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety and pharmacokinetics of AGS-8M4 in adults with advanced ovarian cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• AGS-8M4

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Carcinoma, Ovarian Cancer | Phase 1 | Status: COMPLETED